Клинический случай: применение постоянного положительного давления в дыхательных путях при синдроме обструктивного апноэ сна

1. Olson LJ, Somers VK. Modulation of Cardiovascular Risk Factors by Obstructive Sleep Apnea. Chest 2006; 129: 218-2.0

2. Meyer JS, Ishikawa Y, Hata T et al. Cerebral blood flow in normal and abnormal sleep and dreaming. Brain Cogn 1987; 6: 266-94.

3. ICSD-Internatinal Classification of Sleep Disorders: Diagnostic and Coding Manual. American Sleep Disorders Association. Allen Press, 1990.

4. Brooks D, Kozar L, Render-Telzelra C et al. Obstructive sleep apnea as a cause of systemic hypertension. J Clin Investigat 1997; 99 (1): 106-9.

5. Narkiewicz K, Somers VK. The sympathetic nervous system and obstructive sleep apnea: implications for hypertension. J Hypertens 1997; 15 (12): 1613-9.

6. Silverberg DS, Oksenberg A. Essential hypertension and abnormal upper airway resistance during sleep. Sleep 1997; 20 (9): 794-806

7. Narkiewicz K, van de Borne PJ, Montano N et al. Contribution of tonic chemoreflex activation to sympathetic activation and blood pressure in patients with obstructive sleep apnea. Circulation 1998; 97: 943-5.

8. Carlson JT, Rangemark C. Attenuated endothelium-dependent vascular relaxation in patients with sleep apnea. J Hypertens 1996; 14 (5): 577-8.4

9. Hedner J. Vascular function in OSA. Sleep 1996; 19 (10): 213-7.

10. Saarelainen S, Seppala E. Circulating endothelin-1 in obstructive sleep apnea. Endothelium 1997; 5 (2): 115-8.

11. Remsburg S, Launois SH. Patients with obstructive sleep apnea have an abnormal peripheral vascular response to hypoxia. J Appl Physiol 1999; 87 (3): 1148.

12. Schnall RP, Shlitner A. Periodic, profound peripheral vasoconstriction-a new marker of obstructive sleep apnea. Sleep1999; 22 (7): 939-46.

13. Hall MJ, Bradley TD. Cardiovascular disease and sleep apnea. Curr Opin Pulm Med 1995; 1 (6): 512-8.